维普中文期刊产品整合服务
12篇 您的检索式:作者名="KATHY M H"
    题名 作者 年代 出处 被引量
1Toxicity of selenium and other elements in food organisms to razorback sucker larvae显示文摘Steven J H Kathy M H Kevin J B 2002Aquatic Toxicology2002,59,34:1
2In Vivo Enhancement of Tumor Radioresponse by C225 Antiepidermal Growth Factor Receptor Antibody显示文摘Luka M Kathy M Nancy H 2000Clin Cancer Res2000,6,2:1
3Characterization and cloning of GP50, a Taeaia solium antigen diagnostic for cysticercosis 显示文摘Kathy H Sowmya P Ryan M 2004Molecular Biochemical Parasitology2004,133,:1
4Toxicity of selenium and other elements in food organisms to razorback sucker larvae显示文摘STEVEN J H KATHY M H KEVIN J B 2002Aquatic Toxicology2002,59,34:1
5Lipidlowering effects of ethyl 2-phenacyl-3-aryl-1H-pyrrole-4-carboxylates in rodents 显示文摘JUSTIN M H KATHY O C ADAM G 2004Molecules2004,9,3:1
6Characterization and aquatic impacts if combined sewer overflows in greater Vancouver, British Columbia显示文摘KEN J H DONALD W M KATHY L 1998Water Science and Technology1998,38,10:1
7Enzyme immunoassay for direct detection of influenza type A and adenovirus antigens in clinical specimens显示文摘Maurice W H Kathy M P 1982J Clin Microbiol1982,15,1:1
8Removal of nutrients from secondary-treated municipal wastewater in wetland microcosms using ornamental plant species 显示文摘Zhen H Z Zed R Kathy M 2007International Journal of Environment and Waste Management2007,1,4:1
9Performance of Enzymatically Deinking Recovered Paper on Paper Machine Runnability显示文摘Kathie Rudedge-Cropsey John Klungness H Said Abubakr M 1998Tappi Journal1998,81,2:1
10Angiogenesis as targeted breast cancer therapy 显示文摘DANIEL F H KATHY M GEORGE S 2007The Breast2007,16,2:1
11The Key to Life Nutrition Program: results from a community-based dietary sodium reduction trial显示文摘Joseph F Robare N Carole Milas Constance M Bayles Kathy Williams Anne B Newman Mita T Lovalekar Robert Boudreau Kathleen McTigue Steven M Albert Lewis H Kuller 2009Public Health Nutrition2009,,5:1
12Clinical utilities and end-user experience of pharmacogenomics:39 mo of clinical implementation experience in an Australian hospital setting显示文摘BACKGROUND Pharmacogenomics(PG)testing is under-utilised in Australia.Our research provides Australia-specific data on the perspectives of patients who have had PG testing and those of the clinicians involved in their care,with the aim to inform wider adoption of PG into routine clinical practice.AIM To investigate the frequency of actionable drug gene interactions and assess the perceived utility of PG among patients and clinicians.METHODS We conducted a retrospective audit of PG undertaken by 100 patients at an Australian public hospital genetics service from 2018 to 2021.Via electronic surveys we compared and contrasted the experience,understanding and usage of results between these patients and their clinicians.RESULTS Of 100 patients who had PG,84% were taking prescription medications,of which 67% were taking medications with actionable drug-gene interactions.Twenty-five out of 81 invited patients and 17 out of 89 invited clinicians completed the surveys.Sixty-eight percent of patients understood their PG results and 48% had medications changed following testing.Paired patient-clinician surveys showed patient-perceived utility and experience was positive,contrasting their clinicians’hesitancy on PG adoption who identified insufficient education/training,lack of clinical support,test turnaround time and cost as barriers to adoption.CONCLUSION Our dichotomous findings between the perspectives of our patient and clinician cohorts suggest the uptake of PG is likely to be driven by patients and clinicians need to be prepared to provide information and guidance to their patients.Rosalind Moxham Andrew Tjokrowidjaja Sophie Devery Renee Smyth Alison McLean Darren M Roberts Kathy H C Wu 2023World Journal of Medical Genetics2023,11,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费